Targeting DNA damage repair pathways in pancreas cancer

Volume: 40, Issue: 3, Pages: 891 - 908
Published: Aug 17, 2021
Abstract
Pancreas ductal adenocarcinoma (PDAC) is the third most common cause of cancer death in the USA. While other cancers with historically poor prognoses have benefited from new immunotherapies and targeted agents, the 5-year survival rate for PDAC patients has remained static. The accessibility to genomic testing has improved in recent years, and it is now clear that PDAC is a heterogenous disease, with a subset of patients harboring actionable...
Paper Details
Title
Targeting DNA damage repair pathways in pancreas cancer
DOI
Published Date
Aug 17, 2021
Journal
Volume
40
Issue
3
Pages
891 - 908
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.